Market Overview:
The global famciclovir API market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of herpes virus infections, rising demand for generic drugs, and growing investments in R&D by pharmaceutical companies. The global famciclovir API market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into insourced, outsourced, and others. The outsourced segment is expected to grow at a higher CAGR during the forecast period owing to factors such as lower production costs and shorter turnaround times offered by contract manufacturers. On the basis of application, the market is divided into tablet product, capsule product,, and others. The tablet product segment accounted for a larger share in 2017 owing to its widespread use in various applications such as prescription drugs and over-the-counter (OTC) drugs. Geographically speaking,, North America held a dominant position in 2017 due to high demand for antiviral drugs from both developed countries such as UStS., Canada., etc.,and developing countries such as Mexico,. Brazil,. etc.
Product Definition:
Famciclovir is a synthetic nucleoside analogue with anti-viral activity. It is a prodrug of penciclovir, which is active against herpesviruses. Famciclovir is used to treat infections caused by herpes viruses, including genital herpes, cold sores, and shingles (herpes zoster). It can also be used to prevent recurrent outbreaks of herpes infection.
Insourced:
Insourced is the new term in the market for Famciclovir API. It means that a company has its own production plant for generic drug ingredients and it can produce these drugs at a much lower cost than other companies which have to rely on third-party suppliers.
Outsourced:
Outsourcing is the process of assigning or transferring a company's manufacturing, service, or other operations to another organization. In case of pharmaceutical companies, outsourcing includes the distribution and sale of products such as raw materials and drugs among others.
In recent years there has been an increase in demand for outsourcing by pharmaceutical companies due to various advantages such as cost-effectiveness & efficiency offered in performing certain tasks which include drug development & quality control along with regulatory assistance.
Application Insights:
Based on application, the market is segmented into tablet product, capsule product, others. Tablet products held the largest share in 2017 and are estimated to continue leading during the forecast period owing to high usage rates offamciclovir tablets for chickenpox treatment across various regions.
The use of famciclovir tablets for shingles (herpes zoster) has been increasing over recent years due to its effectiveness in treating this condition along with other related complications such as post-herpetic neuralgia (painful nerve sensations) and cataract formation after infection by HHV-6A or HHV-7. The growing prevalence of shingles infections among older people is expected to drive demand for a specific drug combination that includes famciclovir hydrochloride and acyclovIR which are used for their treatment.
Regional Analysis:
North America dominated the global market in 2017 owing to high product demand and introduction of brand new products. The region is expected to maintain its dominance over the forecast period due to increasing number of product launches coupled with rising awareness about famciclovir treatment. For instance, in June 2018, Sun Pharmaceutical Industries Ltd., India launched a new tablet formulation offamciclovir for treating genital warts and Herpes Simplex Virus (HSV) infections under the brand name Fycompa 200 mg Tablets.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period owing to presence of emerging countries such as China and India which are majorly untapped markets for this medicine. Growing prevalence rateof genital warts virus infection & related diseases along with unmet clinical needs are some factors driving growth in this region.
Growth Factors:
- Increasing incidence of herpes infections: The global herpes infection rate is increasing due to various factors such as changing sexual behavior, increasing number of people with compromised immune systems, and rising awareness about the disease. This is expected to drive the demand for Famciclovir API in the coming years.
- Growing use of antiviral drugs: Antiviral drugs are increasingly being used to treat a wide range of viral infections including herpes simplex virus (HSV), human immunodeficiency virus (HIV), and hepatitis C virus (HCV). This is likely to boost the demand for Famciclovir API in the near future.
- Rising prevalence of sexually transmitted diseases: The global prevalence of sexually transmitted diseases (STDs) is on the rise, owing to factors such as unprotected sex, increased urbanization, and growing popularity of casual sex encounters. This is likely to create a strong demand for Famciclovir API in coming years.
- Technological advancements in drug development: Drug developers are constantly working on developing new and better antiviral drugs that can effectively treat various viral infections including HSV, HIV, and HCV infections..This is expected to result in an increase in demand for Famciclovir API over the next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Famciclovir API Market Research Report
By Type
Insourced, Outsourced, Others
By Application
Tablet Product, Capsule Product, Others
By Companies
Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, Olon, Fuan Pharmaceutical, Zhejiang Charioteer Pharmaceutical, Jialin Pharmaceutical, Zhejiang Hisun, Hetero
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global Famciclovir API Market Report Segments:
The global Famciclovir API market is segmented on the basis of:
Types
Insourced, Outsourced, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet Product, Capsule Product, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Chongqing Shenghuaxi Pharma
- Aurobindo Pharma Limited
- Apotex Pharmachem
- Changzhou Kony Pharma Co
- Teva Pharmaceutical Industries
- Olon
- Fuan Pharmaceutical
- Zhejiang Charioteer Pharmaceutical
- Jialin Pharmaceutical
- Zhejiang Hisun
- Hetero
Highlights of The Famciclovir API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Insourced
- Outsourced
- Others
- By Application:
- Tablet Product
- Capsule Product
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Famciclovir API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Famciclovir API is a software development kit (SDK) that provides developers with the ability to create applications that interact with Famciclovir. The SDK allows developers to access Famciclovir's functionality, including its ability to detect and treat herpes simplex virus infections.
Some of the major players in the famciclovir api market are Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, Olon, Fuan Pharmaceutical, Zhejiang Charioteer Pharmaceutical, Jialin Pharmaceutical, Zhejiang Hisun, Hetero.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Famciclovir API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Famciclovir API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Famciclovir API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Famciclovir API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Famciclovir API Market Size & Forecast, 2020-2028
4.5.1 Famciclovir API Market Size and Y-o-Y Growth
4.5.2 Famciclovir API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Insourced
5.2.2 Outsourced
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Tablet Product
6.2.2 Capsule Product
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Famciclovir API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Famciclovir API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Insourced
9.6.2 Outsourced
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Tablet Product
9.10.2 Capsule Product
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Insourced
10.6.2 Outsourced
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Tablet Product
10.10.2 Capsule Product
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Insourced
11.6.2 Outsourced
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Tablet Product
11.10.2 Capsule Product
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Insourced
12.6.2 Outsourced
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Tablet Product
12.10.2 Capsule Product
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Insourced
13.6.2 Outsourced
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Tablet Product
13.10.2 Capsule Product
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Famciclovir API Market: Competitive Dashboard
14.2 Global Famciclovir API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Chongqing Shenghuaxi Pharma
14.3.2 Aurobindo Pharma Limited
14.3.3 Apotex Pharmachem
14.3.4 Changzhou Kony Pharma Co
14.3.5 Teva Pharmaceutical Industries
14.3.6 Olon
14.3.7 Fuan Pharmaceutical
14.3.8 Zhejiang Charioteer Pharmaceutical
14.3.9 Jialin Pharmaceutical
14.3.10 Zhejiang Hisun
14.3.11 Hetero
